(PharmaNewsWire.Com, January 08, 2018 ) Coagulation testing measures the ability of blood to form a clot. Clotting is the process of the blood converting from a liquid into a gel form. Coagulation tests are carried out to detect clotting disorders such as hemorrhage and thrombosis. Many types of coagulation tests exist, including complete blood count, factor V assay, fibrinogen level, PT, platelet count, TT, and bleeding time.
Covered in this report The report covers the present scenario and the growth prospects of the global point-of-care coagulation testing market for 2016-2020. A 360-degree view of the market, based on products, application, and technology segments, has been considered for market sizing.
The market is divided into the following segments based on geography: - Americas - APAC - EMEA
Publisher's report, Global Point-Of-Care Coagulation Testing Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors - Abbott Laboratories - Alere Inc. - F. Hoffmann-La Roche AG - Siemens AG
Other prominent vendors - Accriva Diagnostics - CoaquSense - Diagon - Helena Point of Care - HemoSonics - iLine Microsystems - Medtronic - Micropoint Bioscience - Sysmex
Market driver - Increase in instances of coagulation disorders driving demand for POCT devices - For a full, detailed list, view our report
Market challenge - High cost of coagulation analyzers - For a full, detailed list, view our report
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: